Excited to say our work on #CMV#letermovir#drugresistance was published today at @BMTjournal; #GVHD ppx with PTCy or CNI/MMF were associated with risk CMV during letermovir prophylaxis. De novo CMV #UL56 resistance was rare overall (<1%).
Nature's BMT: https://t.co/0Trkm4BZma
Thrombus in Transit: A Two-Case Series Highlighting Clinical Challenges and Outcomes"
Two high-risk PE cases highlighting the diagnostic urgency, management uncertainty, and poor outcomes that can occur despite aggressive intervention.
https://t.co/hBkbsPDfeG
#Thrombus#PE
New case report: Cutaneous leishmaniasis is still being missed in the U.S
Chronic auricular ulcer after travel → months of negative biopsies/stains → diagnosis only by Leishmania PCR
Key point: nonhealing ulcers + travel history = think leishmaniasis
https://t.co/1KW5vgE24U
Happy to say our work on viral evolution and how certain mutations - AKA “Knockouts” - can lead to less severe disease in COVID was published today in Nature Communications! @NatureComms@UW @UWVirology @fredhutch@wcassias@trvrb@pavitrarc@GreningerLab
https://t.co/En3Ak4eezd
JPIDS is soliciting drawing submissions that will illustrate the covers of our journal. We are looking for submissions from children that demonstrate unique artistic vision and creativity with a theme that relates to pediatric infectious disease. More at https://t.co/8Lv461GrjK
@DisabledDoctor @FDAHealthEquity I don't think it was intentional, but it is a fair reminder of the importance of alt text. Appreciate you pointing this out
@bfhermann@Savannah_Dimick I would kindly remind that programs get upwards of $100,000 annually from the federal government to train each resident, who works for less than minimum wage for 3+ years after accumulating a knee-popping, crippling student debt
11 years ago today, the FDA approved PrEP to prevent HIV.
Most insurance plans cover PrEP. If you don’t have insurance, there are programs that provide PrEP for free or reduced cost, regardless of immigration status.
Learn more: https://t.co/LU9c8XBPRh
#StopHIVTogether